Member Info for MattTheBrave

Anyone know why the stock's down 6% today, (and down 20% over the last month). Can't simply be more fallout from Dunkerton's divorce-induced sale can it?

...this morning! Any thoughts Rivaldo?

Having had nice run up to 320p earlier in the year, we are now back into the 270s with what looks like a rather persistent seller over the last few days. It appears as though we're range bound (270 to 320) until we see definitive results from the new plants and restructuring undertaken in the last few years. Below 270p, time to add I reckon!!

Thanks TTT, good to know.

So I assume you other holders out there will have received your tender offer. Interested to hear what others might be doing on this? I'm going to tender all of my shares at 250p, fully expecting to sell none, but any that are done at this price, I'll replace by buying back in the market if below 250p.

Yes, disappointing as the stock rose to $14.4 (above £20 UK share) at one point before drifting back.

Good stuff - I'm unable to attend so anything you guys can pass on will be gratefully received.

Wow! That's a pretty ballsy (size of) investment mate.

Fair enough Miti - a gracious response to a slightly cheeky post from me!. We can both agree that the stock's a buy at these levels. I also note that if the 400k you refer to is a sterling figure, then you're dealing in somewhat larger sizes than myself!!

.......long may it continue! Any new anyone's aware of?

...ignore the charts, and decide whether the stock is fundamentally cheap. Buy and wait for the market to arrive at the same conclusion. If stock falls further, and the story hasn't changed, buy more. Repeat. Goes up and gets ahead of itself, then trim. Doesn't always work of course, but I tend to find this a winning strategy over the long term more often than not. NCC is actually a good example of a stock where this strategy has worked very well over the past decade, and will (hopefully) continue to do so!!

I recently came across your October post which you said the following to me: "Matt, Nonsense , you clearly have not researched Nasdaq biotechs wrt valuations. By the time HCM Ipo' s on Nasdaq , you will see the share price closer to 40 than 30 quid imo." Care to comment? Wouldn't normally do this sort of thing, but you were so rude back then (not just this post, but others), I just couldn't help myself...!

Yes, dipped below 240p today on decent volume - difficult to comprehend the price move since Jan based on the half year results, unless I've missed something! With EPS of around 11p this year (to end May) and (hopefully) near 14p in 2017, a PE of around 17x 2017 looks good value for a Company like this - Nice mix of organic growth (around 20%) mixed with strategic acquisitions adding another 10% - 20%. Definitely a buy in my view.

Ok, thanks goldust. Shame it isn't something a bit more fundamental, but I'll take it!!

..and still she rises on no news that I can see. Any thoughts anyone?

So, the stock remains under some pressure here. Do we think this is the 2017 license expiry, or is something else afoot here?

...particularly with regards to the order book, and growth for next year. 50glass - Interesting to see you posting here - you and I seem to follow/invest in a lot of the same stocks (eg MCRO, CMS and VLK).

So, despite the US listing being only a small portion of the Company, it is a significant portion of the free float, and actually has higher volumes than the London listing. This means that the US listing is becoming the defacto primary quote, and further, now means that the UK price is now beholden to currency translation effects ie the sterling dollar rate. Most of today's fall can be explained by the 3% rise in Sterling versus the dollar overnight. Expect more volatility on this basis going forwards.

..a very nice move today on big volume. My target this year is still 70p. Strong buy!

So let me get this right - ST was a buyer. then we got a good set of figures in terms of growth and cash flow. So he the switched to being a seller! Can someone explain that please - I'm confused (and yes, I am easily confused...)